Open the mobile version, with barcode scanning
Class II Ongoing

Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01

Why: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Company
Leading Pharma, LLC
Fairfield, NJ, United States
Reported
Apr 29, 2026
Recall started
Mar 20, 2026
Where sold
US Nationwide.
Amount
9384 bottles
Full product description
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Lots / codes affected
Lots# H03125, H03225, H03325, Exp Date: 2027/08

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.